NOVARTIS AG (NVSEF)
Clinical trial NCT04609592 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-09-01 → 2027-05-01 3. primary completion date: 2026-07-01 → 2026-11-01 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04609592 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-09-01 → 2027-05-01 3. primary completion date: 2026-07-01 → 2026-11-01 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Low confidence analysis (53%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical